Pharmacokinetics, efficacy and tolerability of single-dose granisetron in patients receiving moderately or highly emetogenic chemotherapy
Latest Information Update: 26 Jun 2013
At a glance
- Drugs Granisetron (Primary)
- Indications Chemotherapy-induced nausea and vomiting
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- Sponsors Heron Therapeutics
- 26 Jun 2013 New trial record
- 04 Jun 2013 Results presented at the 49th Annual Meeting of the American Society of Clinical Oncology.